2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow CapOX: new trials by email Literature Review of CapOX trials Research Report on CapOX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib As Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma Pembrolizumab, Olaparib, mFOLFOX-6 - Esophagogastric Adenocarcinoma | Phase 2 | Completed | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 31 | 2022-09-15 | 2025-02-20 |
| NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer Folfox Protocol, Capox - Rectal Cancer | Phase 2 | Completed | Canadian Cancer Trials Group | 58 | 2018-06-29 | 2026-04-09 |
Rectal Neoplasms (1)
Canadian Cancer Trials Group (1) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1)
Canada (1) · Germany (1) · United States (1)
Carl Brown (1) · Georg Martin Haag, PD Dr. (1) · Hagen Kennecke (1) · Salah-Eddin Al-Batran, Prof. Dr. (1)